Where should pharma invest to remain at the forefront of healthcare?
New technologies coming along to disrupt the pharma industry.
How do the countries of the UK fund cancer drugs today, and do they have the right approaches?
Partnerships, co-marketing and the positioning of drugs are shaping the competitive landscape in oncology.
Health literacy study suggests more than 90% of adults need health information to be written for a reading age of 9-11 years.
Are cancer screening and diagnosis swift enough, and how effective are the latest tailored drugs?
A practical guide to planning and running an effective patient support programme.
Charities must work to help pharma and academia prioritise and accelerate paediatric treatments.